AUTOMATED GMP-COMPATIBLE CRISPR-CAS9 EDITING OF HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) FOR THE TREATMENT OF β-HEMOGLOBINOPATHIES

被引:0
|
作者
Urena-Bailen, G. [1 ,2 ]
Block, M.
机构
[1] Miltenyi Biotec BV & Co KG, Bergisch Gladbach, Nordrhein Westf, Germany
[2] Univ Klinikum Tubingen, Oncol & Hematol, Tubingen, Baden Wurttembe, Germany
关键词
beta-hemoglobnopathies; GMP-compatible; CRISPR-Cas9;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
402
引用
收藏
页码:S124 / S124
页数:1
相关论文
共 50 条
  • [31] Barcoded Clonal Tracking of CRISPR-Cas9 and rAAV6-Mediated Gene Targeting in Human Hematopoietic Stem and Progenitor Cells
    Dever, Daniel P.
    Sharma, Rajiv
    Lee, Ciaran M.
    Aziz, Armon
    Koehnke, Thomas
    Camarena, Joab
    Pan, Yidan
    Zhao, Feifei
    Bao, Gang
    Majeti, Ravindra
    Porteus, Matthew
    MOLECULAR THERAPY, 2019, 27 (04) : 5 - 5
  • [32] FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells
    Caillaud, Amandine
    Leveque, Antoine
    Thedrez, Aurelie
    Girardeau, Aurore
    Canac, Robin
    Bray, Lise
    Baudic, Manon
    Barc, Julien
    Gaborit, Nathalie
    Lamirault, Guillaume
    Gardie, Betty
    Idriss, Salam
    Rimbert, Antoine
    May, Cedric Le
    Cariou, Bertrand
    Si-Tayeb, Karim
    STAR PROTOCOLS, 2022, 3 (04):
  • [33] Resistance of Mouse Hematopoietic Stem and Progenitor Cells to the Genome-Editing with Cas9
    Byambaa, Suvd
    Uosaki, Hideki
    Hara, Hiromasa
    Abe, Tomoyuki
    Nagao, Yasumitsu
    Nureki, Osamu
    Ohmori, Tsukasa
    Hanazono, Yutaka
    MOLECULAR THERAPY, 2017, 25 (05) : 93 - 93
  • [34] CRISPR/Cas9 Edited Hematopoietic Stem and Progenitor Cells for Friedreich's Ataxia
    Sivakumar, Anusha
    Badell-Grau, Rafael Andres
    Wan, Rita
    Khare, Veenita
    Cherqui, Stephanie
    MOLECULAR THERAPY, 2023, 31 (04) : 639 - 639
  • [35] Priming Hematopoietic Stem and Progenitor Cells for CRISPR/Cas9-Mediated Homologous Recombination
    Camarena, Joab
    Charlesworth, Carsten T.
    Bak, Rasmus O.
    Carte, Jason
    Potter, Jason
    Dever, Daniel D.
    Porteus, Matthew H.
    MOLECULAR THERAPY, 2017, 25 (05) : 78 - 78
  • [36] A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells
    Jayavaradhan, Rajeswari
    Pillis, Devin M.
    Malik, Punam
    JOURNAL OF MOLECULAR BIOLOGY, 2019, 431 (01) : 102 - 110
  • [37] A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    della Volpe, Lucrezia
    Midena, Federico
    Vacca, Roberta
    Tavella, Teresa
    Alessandrini, Laura
    Farina, Giacomo
    Brandas, Chiara
    Lo Furno, Elena
    Giannetti, Kety
    Carsana, Edoardo
    Naldini, Matteo M.
    Barcella, Matteo
    Ferrari, Samuele
    Beretta, Stefano
    Santoro, Antonella
    Porcellini, Simona
    Varesi, Angelica
    Gilioli, Diego
    Conti, Anastasia
    Merelli, Ivan
    Gentner, Bernhard
    Villa, Anna
    Naldini, Luigi
    Di Micco, Raffaella
    CELL REPORTS MEDICINE, 2024, 5 (11)
  • [38] Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
    Cromer, M. Kyle
    Barsan, Valentin V.
    Jaeger, Erich
    Wang, Mengchi
    Hampton, Jessica P.
    Chen, Feng
    Kennedy, Drew
    Xiao, Jenny
    Khrebtukova, Irina
    Granat, Ana
    Truong, Tiffany
    Porteus, Matthew H.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [39] Ultra-deep sequencing validates safety of CRISPR/Cas9 genome editing in human hematopoietic stem and progenitor cells
    M. Kyle Cromer
    Valentin V. Barsan
    Erich Jaeger
    Mengchi Wang
    Jessica P. Hampton
    Feng Chen
    Drew Kennedy
    Jenny Xiao
    Irina Khrebtukova
    Ana Granat
    Tiffany Truong
    Matthew H. Porteus
    Nature Communications, 13
  • [40] The Cytotoxic Effect of RNA-Guided Endonuclease Cas9 on Human Hematopoietic Stem and Progenitor Cells (HSPCs)
    Yu, Kyung-Rok
    Corat, Marcus A. F.
    Metais, Jean-Yves
    Dunbar, Cynthia E.
    MOLECULAR THERAPY, 2016, 24 : S225 - S226